Deal funds product development, inventory purchases, working capital
By Devika Patel
Knoxville, Tenn., Dec. 21 - LED Medical Diagnostics Inc. said it raised C$325,000 in the second and final tranche of a C$1.16 million non-brokered expedited private placement of stock. The deal, which was slated to raise about C$1 million, raised C$837,500 on Dec. 19.
The company sold 4.65 million common shares at C$0.25 per share. The price per share represents a 7.41% discount to C$0.27, the Dec. 18 closing share price. In the first tranche, LED sold 3.35 million shares; it sold 1.3 million shares in the second tranche.
Proceeds will be used to support product development, to purchase inventory and for working capital purposes.
Based in Burnaby, B.C., LED develops and commercializes medical devices based on its imaging platform to aid in the detection and treatment of disease in human tissues.
| Issuer: | LED Medical Diagnostics Inc.
|
| Issue: | Common shares
|
| Amount: | C$1,162,500
|
| Shares: | 4.65 million
|
| Price: | C$0.25
|
| Warrants: | No
|
| Agent: | Non-brokered
|
| Settlement date: | Dec. 19 (for C$837,500), Dec. 21 (for C$325,000)
|
| Stock symbol: | TSX Venture: LMD
|
| Stock price: | C$0.27 at close Dec. 18
|
| Market capitalization: | C$9.08 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
